Sonova Holding (SONVF) Fair Value & Analysis
Healthcare · US · Market cap $14.5B
Sonova Holding
SONVF · US
Fair value as of: Jul 19, 2026
From 26 valuation models · updated 4 days ago
Fair value updated Jul 19, 2026, revised from $196.56 to $197.61 (+0.5%) since Jun 24, 2026. Share price +0.1% over the past month.
Price vs Fair Value (12 months)
12‑month range $208.55 – $374.57 · fair‑value band $122.62 – $247.02 · the $244.08 price screens above the $197.61 fair value. As of Jul 19, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Sonova Holding (SONVF) currently trades at $244.08, while our model-based Fair Value estimate is $197.61, implying the stock looks roughly 19.0% overvalued today. We read business quality at 58/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Sonova Holding generated revenue of $3.6B at a net margin of 11.9%. Revenue declined 1.0% year over year. It earns a return on equity of 20.5%. Net debt stands at $990M. Fundamentals as of Jul 19, 2026
Our scenario range runs from $122.62 (bear case) to $247.02 (bull case); at $244.08, the current price sits within that range. The share trades about 22% below its 52-week high and 17% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -24% fair-value upside, at -19%, SONVF screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 19, 2026. TTM = trailing twelve months.
About the company
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing instruments and related products under the Advanced Bionics brand. The Lifestyle-Aligned segment designs …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Sonova Holding reported revenue of $3.6B in FY2026 versus $3.4B in FY2022, a compound +1.8%/yr. Reported net income was $431M in FY2026, compounding −9.7%/yr from FY2022.
Is SONVF fairly valued? → Check now
Recent news
- IART or SONVY: Which Is the Better Value Stock Right Now?
- IART vs. SONVY: Which Stock Is the Better Value Option?
- Sonova Holding AG (SONVF) Full Year 2026 Earnings Call Highlights: Strong Growth Amidst Market ...
- Annual General Meeting 2026: Sonova Shareholders Approve all Board of Directors' Motions
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection, not financial advice.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $89.17 | $70.59 | -21% |
| Stryker Corporation SYK | $308.84 | $187.83 | -39% |
| Medtronic plc MDTC34 | R$211.05 | R$29.52 | -86% |
| Boston Scientific Corporation B1SX34 | R$247.01 | R$234.82 | -5% |
| Edwards Lifesciences Corporation EWL | €75.90 | €37.29 | -51% |
| Siemens Healthineers AG SEMHF | $39.95 | $44.36 | +11% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥141.85 | ¥147.63 | +4% |
| STERIS plc S1TE34 | R$52.14 | R$39.50 | -24% |
| Zimmer Biomet Holdings Z1BH34 | R$116.16 | R$85.57 | -26% |
| Shanghai United Imaging Healthcare Co 688271 | ¥104.19 | ¥45.36 | -56% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Sonova Holding (SONVF) undervalued?
What is the fair value of SONVF?
What is the quality score of SONVF?
What is the revenue of Sonova Holding (SONVF)?
What is the net profit margin of SONVF?
Does Sonova Holding pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Sonova Holding analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.